Literature DB >> 9445390

tRNA is entrapped in similar, but distinct, nuclear and cytoplasmic ribonucleoprotein complexes, both of which contain vigilin and elongation factor 1 alpha.

C Kruse1, A Grünweller, D K Willkomm, T Pfeiffer, R K Hartmann, P K Müller.   

Abstract

Vigilin, which is found predominantly in cells and tissues with high levels of protein biosynthesis, was isolated in its native form from human HEp-2 cells (A.T.C.C. CCL23) by immunoaffinity chromatography. Here we demonstrate that vigilin is part of a novel large tRNA-binding ribonucleoprotein complex (tRNP), found not only in the cytoplasm, but also in the nuclei of human cells. Compositional differences in the protein pattern were detected between the nuclear and cytoplasmic tRNPs, although some properties of the purified nuclear tRNP, such as tRNA protection against nuclease attack, were identical with those of the cytoplasmic tRNP. By using either a pool of total human nuclear RNA or radioactively labelled yeast tRNAAsp in rebinding experiments, we could show that tRNA is specifically recaptured by the RNA-depleted, vigilin-containing nuclear complex. We could also show that vigilin is capable of binding tRNA in vitro. Another tRNA-binding protein is elongation factor 1 alpha, which appears to be enriched in the cytoplasmic and nuclear tRNP complexes. This suggests that the cytoplasmic tRNP may be involved in the channelled tRNA cycle in the cytoplasm of eukaryotic cells. Our results also suggest that the nuclear vigilin-containing tRNP may be related to the nuclear export of tRNA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9445390      PMCID: PMC1219084          DOI: 10.1042/bj3290615

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  36 in total

1.  The Balbiani ring particle: a model for the assembly and export of RNPs from the nucleus?

Authors:  H Mehlin; B Daneholt
Journal:  Trends Cell Biol       Date:  1993-12       Impact factor: 20.808

2.  Identification of bases in 16S rRNA essential for tRNA binding at the 30S ribosomal P site.

Authors:  U von Ahsen; H F Noller
Journal:  Science       Date:  1995-01-13       Impact factor: 47.728

3.  Immunocytochemical localization of vigilin, a tRNA-binding protein, after cell fractionation and within the exocrine pancreatic cell of the rat.

Authors:  M H Klinger; C Kruse
Journal:  Ann Anat       Date:  1996-08       Impact factor: 2.698

Review 4.  Elongation factor 1 alpha, translation and the cytoskeleton.

Authors:  J Condeelis
Journal:  Trends Biochem Sci       Date:  1995-05       Impact factor: 13.807

5.  Vigilin contains a functional nuclear localisation sequence and is present in both the cytoplasm and the nucleus.

Authors:  S Kügler; A Grünweller; C Probst; M Klinger; P K Müller; C Kruse
Journal:  FEBS Lett       Date:  1996-03-18       Impact factor: 4.124

Review 6.  Conserved structures and diversity of functions of RNA-binding proteins.

Authors:  C G Burd; G Dreyfuss
Journal:  Science       Date:  1994-07-29       Impact factor: 47.728

7.  A nuclear cap binding protein complex involved in pre-mRNA splicing.

Authors:  E Izaurralde; J Lewis; C McGuigan; M Jankowska; E Darzynkiewicz; I W Mattaj
Journal:  Cell       Date:  1994-08-26       Impact factor: 41.582

8.  The human U1 snRNP-specific U1A protein inhibits polyadenylation of its own pre-mRNA.

Authors:  W C Boelens; E J Jansen; W J van Venrooij; R Stripecke; I W Mattaj; S I Gunderson
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

9.  Chicken vigilin gene organization and expression pattern. The domain structure of the protein is reflected by the exon structure.

Authors:  B Henkel; C Schmidt; H Zorbas; E Pöschl; T R Gloe; W G Purschke; P K Müller
Journal:  Eur J Biochem       Date:  1992-10-01

10.  Diverse effects of the guanine nucleotide exchange factor RCC1 on RNA transport.

Authors:  Y Cheng; J E Dahlberg; E Lund
Journal:  Science       Date:  1995-03-24       Impact factor: 47.728

View more
  8 in total

1.  Decoding apparatus for eukaryotic selenocysteine insertion.

Authors:  R M Tujebajeva; P R Copeland; X M Xu; B A Carlson; J W Harney; D M Driscoll; D L Hatfield; M J Berry
Journal:  EMBO Rep       Date:  2000-08       Impact factor: 8.807

2.  Export and transport of tRNA are coupled to a multi-protein complex.

Authors:  C Kruse; D K Willkomm; A Grünweller; T Vollbrandt; S Sommer; S Busch; T Pfeiffer; J Brinkmann; R K Hartmann; P K Müller
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

3.  Asc1p, a WD40-domain containing adaptor protein, is required for the interaction of the RNA-binding protein Scp160p with polysomes.

Authors:  Sonja Baum; Margarethe Bittins; Steffen Frey; Matthias Seedorf
Journal:  Biochem J       Date:  2004-06-15       Impact factor: 3.857

4.  DDP1, a heterochromatin-associated multi-KH-domain protein of Drosophila melanogaster, interacts specifically with centromeric satellite DNA sequences.

Authors:  A Cortés; F Azorín
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

5.  RNAi-mediated depletion of the 15 KH domain protein, vigilin, induces death of dividing and non-dividing human cells but does not initially inhibit protein synthesis.

Authors:  Kathryn M Goolsby; David J Shapiro
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

6.  Scp160p, a multiple KH-domain protein, is a component of mRNP complexes in yeast.

Authors:  B D Lang; J L Fridovich-Keil
Journal:  Nucleic Acids Res       Date:  2000-04-01       Impact factor: 16.971

7.  Dissecting FMR1, the protein responsible for fragile X syndrome, in its structural and functional domains.

Authors:  S Adinolfi; C Bagni; G Musco; T Gibson; L Mazzarella; A Pastore
Journal:  RNA       Date:  1999-09       Impact factor: 4.942

8.  Scp160p is required for translational efficiency of codon-optimized mRNAs in yeast.

Authors:  Wolf D Hirschmann; Heidrun Westendorf; Andreas Mayer; Gina Cannarozzi; Patrick Cramer; Ralf-Peter Jansen
Journal:  Nucleic Acids Res       Date:  2014-01-20       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.